Corrigendum to A novel co-culture model of the blood-retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes [Exp. Eye Res. 96, 1, (2012), 181-190] DOI: 10.1016/j.exer.2011.12.003;A novel co-culture model of the blood-retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes

Experimental Eye Research

Volumn 96, Issue 1, 2012, Pages 181-190

  Wisniewska Kruk, Joanna ^a   Hoeben, Kees A ^a   Vogels, Ilse M C ^a   Gaillard, Pieter J ^b   Van Noorden, Cornelis J F ^a   Schlingemann, Reinier O ^a,c   Klaassen, Ingeborg ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b To BBB Technologies BV   (Netherlands)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Blood brain barrier; Blood retinal barrier; Caveolae; Diabetic retinopathy; Endothelial cells; Tight junctions; Vascular permeability; VEGF

Indexed keywords

CLAUDIN 5; GLUCOSE TRANSPORTER 1; MEMBRANE PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; OCCLUDIN; PLASMALEMMA VESICLE ASSOCIATED PROTEIN; PROTEIN ZO1; TRACER; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; BLOOD RETINA BARRIER; BOVINE RETINAL ENDOTHELIAL CELL; CELL CULTURE; CELL JUNCTION; CELL LINE; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL TYPE; COCULTURE; CONTROLLED STUDY; COW; DIABETIC MACULAR EDEMA; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIA CELL; HISTOPATHOLOGY; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RECEPTOR DOWN REGULATION; RETINA CELL; TRANS ENDOTHELIAL RESISTANCE;

EID: 84857798063     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2015.07.006     Document Type: Erratum

References (57)

1. Abbott N.J., Ronnback L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006, 7:41-53.
2. Andersen C.L., Jensen J.L., Ørntoft T.F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004, 64:5245-5250.
3. Antonetti D.A., Barber A.J., Khin S., Lieth E., Tarbell J.M., Gardner T.W. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn. State Retina Research Group. Diabetes 1998, 47:1953-1959.
4. Antonetti D.A., Barber A.J., Hollinger L.A., Wolpert E.B., Gardner T.W. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occludin 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J. Biol. Chem. 1999, 274:23463-23467.
5. Armulik A., Genové G., Mäe M., Nisancioglu M.H., Wallgard E., Niaudet C., He L., Norlin J., Lindblom P., Strittmatter K., Johansson B.R., Betsholtz C. Pericytes regulate the blood-brain barrier. Nature 2010, 468:557-561.
6. Barber A.J., Antonetti D.A. Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats. Invest. Ophthalmol. Vis. Sci. 2003, 44:5410-5416.
7. Calabria A.R., Weidenfeller C., Jones A.R., de Vries H.E., Shusta E.V. Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction. J. Neurochem. 2006, 97:922-933.
8. Cecchelli R., Dehouck B., Descamps L., Fenart L., Buee-Scherrer V., Duhem C., Lundquist S., Rentfel M., Torpier G., Dehouck M.P. In vitro model for evaluating drug transport across the blood-brain barrier. Adv. Drug Deliv. Rev. 1999, 36:165-178.
9. Cecchelli R., Berezowski V., Lundquist S., Culot M., Renftel M., Dehouck M.P., Fenart L. Modelling of the blood-brain barrier in drug discovery and development. Nat. Rev. Drug. Discov. 2007, 6:650-661.
10. Cohen-Kashi Malina K., Cooper I., Teichberg V.I. Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness. Brain Res. 2009, 1284:12-21.
11. Dejana E. Endothelial cell-cell junctions: happy together. Nat. Rev. Mol. Cell. Biol. 2004, 5:261-270.
12. Dejana E., Tournier-Lasserve E., Weinstein B.M. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev. Cell. 2009, 16:209-221.
13. Deli M.A., Abraham C.S., Niwa M., Falus A. N, N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine increases the permeability of primary mouse cerebral endothelial cell monolayers. Inflamm. Res. 2003, 52(Suppl. 1):S39-S40.
14. Deli M.A., Abraham C.S., Kataoka Y., Niwa M. Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell. Mol. Neurobiol. 2005, 25:59-127.
15. Demeuse P., Kerkhofs A., Struys-Ponsar C., Knoops B., Remacle C., van den Bosch de Aguilar P. Compartmentalized coculture of rat brain endothelial cells and astrocytes: a syngenic model to study the blood-brain barrier. J. Neurosci. Methods 2002, 121:21-31.
16. Dore-Duffy P. Pericytes: pluripotent cells of the blood brain barrier. Curr. Pharm. Des. 2008, 14:1581-1593.
17. Elias B.C., Suzuki T., Seth A., Giorgianni F., Kale G., Shen L., Turner J.R., Naren A., Desiderio D.M., Rao R. Phosphorylation of Tyr-398 and Tyr-402 in occludin prevents its interaction with ZO-1 and destabilizes its assembly at the tight junctions. J. Biol. Chem. 2009, 284:1559-1569.
18. Eng L.F. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J. Neuroimmunol. 1985, 8:203-214.
19. Feng Y., Venema V.J., Venema R.C., Tsai N., Behzadian M.A., Caldwell R.B. VEGF-induced permeability increase is mediated by caveolae. Invest. Ophthalmol. Vis. Sci. 1999, 40:157-167.
20. Feng Y., Venema V.J., Venema R.C., Tsai N., Caldwell R.B. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem. Biophys. Res. Commun. 1999, 256:192-197.
21. Gaillard P.J., de Boer A.G. 2B-Trans technology: targeted drug delivery across the blood-brain barrier. Methods Mol. Biol. 2008, 437:161-175.
22. Gaillard P.J., van der Sandt I.C., Voorwinden L.H., Vu D., Nielsen J.L., de Boer A.G., Breimer D.D. Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier. Pharm. Res. 2000, 17:1198-1205.
23. Gaillard P.J., Voorwinden L.H., Nielsen J.L., Ivanov A., Atsumi R., Engman H., Ringbom C., de Boer A.G., Breimer D.D. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur. J. Pharm. Sci. 2001, 12:215-222.
24. Greenwood J. Characterization of a rat retinal endothelial cell culture and the expression of P-glycoprotein in brain and retinal endothelium in vitro. J. Neuroimmunol. 1992, 39:123-132.
25. Hammes H.P., Lin J., Renner O., Shani M., Lundqvist A., Betsholtz C., Brownlee M., Deutsch U. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 2002, 51:3107-3112.
26. Harhaj N.S., Felinski E.A., Wolpert E.B., Sundstrom J.M., Gardner T.W., Antonetti D.A. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest. Ophthalmol. Vis. Sci. 2006, 47:5106-5115.
27. Hartsock A., Nelson W.J. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim. Biophys. Acta 2008, 1778:660-669.
28. Hayashi K., Nakao S., Nakaoke R., Nakagawa S., Kitagawa N., Niwa M. Effects of hypoxia on endothelial/pericytic co-culture model of the blood-brain barrier. Regul. Pept. 2004, 123:77-83.
29. Hofman P., Blaauwgeers H.G., Tolentino M.J., Adamis A.P., Nunes Cardozo B.J., Vrensen G.F., Schlingemann R.O. VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A. Curr. Eye Res. 2000, 21:637-645.
30. Hofman P., Blaauwgeers H.G., Vrensen G.F., Schlingemann R.O. Role of VEGF-A in endothelial phenotypic shift in human diabetic retinopathy and VEGF-A-induced retinopathy in monkeys. Ophthalmic. Res. 2001, 33:156-162.
31. Hosoya K.-I., Tomi M. Inner blood-retinal barrier: transport biology and methodology. Drug Absorption Studies 2008, vol. 7:321-338. Springer, New York.
32. Klaassen I., Hughes J.M., Vogels I.M., Schalkwijk C.G., Van Noorden C.J., Schlingemann R.O. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes. Exp. Eye Res. 2009, 89:4-15.
33. Murakami T., Felinski E.A., Antonetti D.A. Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J. Biol. Chem. 2009, 284:21036-21046.
34. Murata T., Ishibashi T., Khalil A., Hata Y., Yoshikawa H., Inomata H. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic. Res. 1995, 27:48-52.
35. Murata T., Nakagawa K., Khalil A., Ishibashi T., Inomata H., Sueishi K. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab. Invest. 1996, 74:819-825.
36. Nakagawa S., Deli M.A., Nakao S., Honda M., Hayashi K., Nakaoke R., Kataoka Y., Niwa M. Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells. Cell. Mol. Neurobiol. 2007, 27:687-694.
37. Nakagawa S., Deli M.A., Kawaguchi H., Shimizudani T., Shimono T., Kittel A., Tanaka K., Niwa M. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem. Int. 2009, 54:253-263.
38. Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., Furuse M., Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 2003, 161:653-660.
39. Perriere N., Demeuse P.H., Garcia R.A., Debray M., Andreux J.-P., Couvreur P., Scherman J.-M., Temsamani J., Courand P.-O., Deli M.A., Roux F. Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J. Neurochem. 2005, 93:279-289.
40. Rafiee P., Heidemann J., Ogawa H., Johnson N.A., Fisher P.J., Li M.S., Otterson M.F., Johnson C.P., Binion D.G. Cyclosporin A differentially inhibits multiple steps in VEGF induced angiogenesis in human microvascular endothelial cells through altered intracellular signaling. Cell. Commun. Signal. 2004, 2:3.
41. Rubin L.L., Hall D.E., Porter S., Barbu K., Cannon C., Horner H.C., Janatpour M., Liaw C.W., Manning K., Morales J., Tanner L.I., Tomaselli K.J., Bard F. A cell culture model of the blood-brain barrier. J. Cell Biol. 1991, 115:1725-1735.
42. Ruiter D.J., Schlingemann R.O., Rietveld F.J., de Waal R.M. Monoclonal antibody-defined human endothelial antigens as vascular markers. J. Invest. Dermatol. 1989, 93:25S-32S.
43. Runkle E.A., Antonetti D.A. The blood-retinal barrier: structure and functional significance. Methods Mol. Biol. 2011, 686:133-148.
44. Schlingemann R.O., Dingjan G.M., Emeis J.J., Blok J., Warnaar S.O., Ruiter D.J. Monoclonal antibody PAL-E specific for endothelium. Lab. Invest. 1985, 52:71-76.
45. Schlingemann R.O., Rietveld F.J., de Waal R.M., Ferrone S., Ruiter D.J. Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds. Am. J. Pathol. 1990, 136:1393-1405.
46. Schlingemann R.O., Hofman P., Anderson L., Troost D., van der Gaag R. Vascular expression of endothelial antigen PAL-E indicates absence of blood-ocular barriers in the normal eye. Ophthalmic Res. 1997, 29:130-138.
47. Schlingemann R.O., Hofman P., Vrensen G.F., Blaauwgeers H.G. Increased expression of endothelial antigen PAL-E in human diabetic retinopathy correlates with microvascular leakage. Diabetologia 1999, 42:596-602.
48. Singh A., Stewart J.M. Pathophysiology of diabetic macular edema. Int. Ophthalmol. Clin. 2009, 49:1-11.
49. Takata K., Kasahara T., Kasahara M., Ezaki O., Hirano H. Ultracytochemical localization of the erythrocyte/HepG2-type glucose transporter (GLUT1) in cells of the blood-retinal barrier in the rat. Invest. Ophthalmol. Vis. Sci. 1992, 33:377-383.
50. Tornquist P., Alm A., Bill A. Permeability of ocular vessels and transport across the blood-retinal-barrier. Eye (Lond) 1990, 4:303-309.
51. Vinores S.A., Youssri A.I., Luna J.D., Chen Y.-S., Bhargave S., Vinores M.A., Schoenfeld C.-L., Peng B., Chan Ch., La Rochelle W., Green W.R., Campochiaro P.A. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol. Histopathol. 1997, 12:99-109.
52. Wang W., Dentler W.L., Borchardt R.T. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H434-H440.
53. Wang J., Xu X., Elliott M.H., Zhu M., Le Y.Z. Muller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes 2010, 59:2297-2305.
54. Weidenfeller C., Schrot S., Zozulya A., Galla H.J. Murine brain capillary endothelial cells exhibit improved barrier properties under the influence of hydrocortisone. Brain Res. 2005, 1053:162-174.
55. Weidenfeller C., Svendsen C.N., Shusta E.V. Differentiating embryonic neural progenitor cells induce blood-brain barrier properties. J. Neurochem. 2007, 101:555-565.
56. Witmer A.N., Vrensen G.F., Van Noorden C.J., Schlingemann R.O. Vascular endothelial growth factors and angiogenesis in eye disease. Prog. Retin. Eye Res. 2003, 22:1-29.
57. Xu H., Zeng L., Peng H., Chen S., Jones J., Chew T., Sadeghi M.M., Kanwar Y.S., Danesh F.R. HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation. Am. J. Physiol. Renal. Physiol. 2006, 291:F995-F1004.